Barry L. Carter PharmD, FCCP, FAMA, FASH, FAPHA
Dr. Carter received his B.S. in pharmacy from the University of Iowa in 1978
and his Pharm.D. from the Medical College of Virginia, Virginia Commonweath
University in 1980. He completed a postdoctoral fellowship in Family Practice
at the Univerity of Iowa in 1981. He has served on the faculties of the
University of Iowa (1981-1988), University of Houston and the Baylor College of
Medicine (1988-1991), University of Illinois at Chicago (1991-1995) and he was
the Chairman of the Department of Pharmacy Practice at the University of
Colorado (1995-2000). Carter returned to the University of Iowa in 2000 to
focus on his research program.
Dr. Carter is an internationally recognized expert in hypertension and
team-based care. He is the recipient of 4 NIH R01 grants totaling over $17 million
since 2003. These grants have supported his research involving
physician-pharmacist collaborative models to improve the treatment of
hypertension, improving adherence to hypertension guidelines and strategies to
provide continuity of care between inpatient and community settings. He has
received several research achievement awards from the American College of
Clinical Pharmacy, American Society of Health-System Pharmacists and the
American Pharmacists Association.
Dr. Carter is a past President of the American College of Clinical Pharmacy.
He is a Fellow in the American Heart Association Council on High Blood Pressure
Research (FAHA), a Fellow in the American College of Clinical Pharmacy (FCCP)
and a Fellow in the American Society of Hypertension (FASH). He is a board
certified pharmacotherapy specialist. He was a member of the National Heart,
Lung, and Blood Insititute’s Fifth, Sixth and Seventh Joint National Committees
on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-5,
6 & 7). He of the current national hypertension guideline committee (JNC-8)
which is scheduled to be released in late 2012.